KNSA vs AMGN: Which Stock is Better?

Side-by-side comparison of Kiniksa Pharmaceuticals International Plc and Amgen Inc in 2026

Comparison Updated:

KNSA

Kiniksa Pharmaceuticals International Plc

$47.30

AMGN

Amgen Inc

$349.82

Key Metrics Comparison

MetricKNSAAMGNWinner
Market Cap$3.60B$189.22BAMGN
P/E Ratio62.7724.68AMGN
EPS (TTM)$0.75$14.22AMGN
Revenue Growth0.7%0.1%KNSA
Gross Margin54.7%70.8%AMGN

Analyze KNSA

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is KNSA or AMGN a better investment?

Comparing KNSA and AMGN: Kiniksa Pharmaceuticals International Plc has a market cap of $3.60B while Amgen Inc has $189.22B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between KNSA and AMGN?

KNSA (Kiniksa Pharmaceuticals International Plc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: KNSA or AMGN?

Based on P/E ratios, AMGN trades at a lower multiple (24.7x vs 62.8x).

Which is growing faster: KNSA or AMGN?

KNSA has higher revenue growth at 0.7% vs 0.1% for AMGN.

Which company is more profitable: KNSA or AMGN?

Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 54.7% for KNSA.

Which is the larger company: KNSA or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $189.22B compared to $3.60B for KNSA.

Should I buy KNSA or AMGN in 2026?

Both KNSA and AMGN have investment merit. KNSA trades at $47.30 while AMGN trades at $349.82. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between KNSA and AMGN stock?

Key differences: Market Cap ($3.60B vs $189.22B), P/E Ratio (62.8x vs 24.7x), Revenue Growth (0.7% vs 0.1%), Gross Margin (54.7% vs 70.8%).

Popular Stock Comparisons